Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kiniksa Pharmaceuticals International (KNSA) Change in Intangibles (2021)

Historic Change in Intangibles for Kiniksa Pharmaceuticals International (KNSA) over the last 1 years, with Q1 2021 value amounting to $20.0 million.

  • Kiniksa Pharmaceuticals International's Change in Intangibles changed N/A to $20.0 million in Q1 2021 from the same period last year, while for Dec 2021 it was $20.0 million, marking a year-over-year change of. This contributed to the annual value of $20.0 million for FY2021, which is N/A changed from last year.
  • As of Q1 2021, Kiniksa Pharmaceuticals International's Change in Intangibles stood at $20.0 million.
  • In the past 5 years, Kiniksa Pharmaceuticals International's Change in Intangibles registered a high of $20.0 million during Q1 2021, and its lowest value of $20.0 million during Q1 2021.